Publication at Faculty of Medicine in Pilsen |
2015
Abstract
Inflammatory bowel diseases (IBD) can affect mainly young people in their reproductive years. IBD therefore has a major impact on patient's family planning decisions.
Management of IBD in pregnancy requires a challenging balance between optimal disease control and drug safety. Studies have shown a lack of knowledge among both patients and physicians regarding reproductive issues in IBD.
The aim of this article is to objective review available research data regarding the safety of IBD medication during pregnancy and postpartum period in women with inflammatory bowel disease.